3,4-dihydroxyphenylacetic acid has been researched along with Coronary Disease in 3 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response curve for verapamil was bell-shaped and the activity resided in the l form." | 1.27 | An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts. ( Nayler, WG; Sturrock, WJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nayler, WG | 1 |
| Sturrock, WJ | 1 |
| Endo, T | 1 |
| Hara, S | 1 |
| Kuriiwa, F | 1 |
| Kano, S | 1 |
| Lehnert, H | 1 |
| Lombardi, F | 1 |
| Raeder, EA | 1 |
| Lorenzo, AV | 1 |
| Verrier, RL | 1 |
| Lown, B | 1 |
| Wurtman, RJ | 1 |
3 other studies available for 3,4-dihydroxyphenylacetic acid and Coronary Disease
| Article | Year |
|---|---|
An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Coronary Disease; Diltiazem; Dopamine; Epinep | 1984 |
Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Asphyxia; Cause of Death; Chromatogr | 1990 |
Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cats; Coron | 1987 |